# AmplioSpeech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ampliospeech

- Industry: Education/Training
- Headquarters: Rockville, US
- Website: www.ampliospeech.com
- Total disclosed funding: $28M
- Latest round: Series A (Apr 5, 2021)
- Investors on record: 4

## About

AmplioSpeech Inc., based in the US, specializes in enhancing communication through innovative speech therapy solutions, utilizing AI technology to deliver personalized therapy sessions for individuals with speech disorders.AmplioSpeech Inc. provides cloud-based speech therapy solutions for individuals with speech disorders. Founded in 2014 and headquartered in Rockville, US, the company was established by Ofer Amir, Shirley Shapira, and Yair Shapira. In April 2021, AmplioSpeech raised USD 27.00 mn in a Series A funding round led by Quad Partners, with participation from Volos Capital, bringing the total amount raised to USD 27.00 mn. The company has executed 8 deals as of the latest deal date in 2021.AmplioSpeech specializes in innovative speech therapy solutions designed to enhance communication for individuals with speech disorders. Their primary product offering is a cloud-based platform that leverages artificial intelligence to provide personalized speech therapy exercises. The platform supports various end users, including children with speech delays and adults recovering from speech impairments due to medical conditions. AmplioSpeech’s services are structured to facilitate easy access for both therapists and patients, allowing for real-time progress tracking and tailored therapy sessions. The company primarily serves clients in North America and Europe, focusing on educational institutions, healthcare facilities, and individual consumers seeking effective speech therapy solutions.AmplioSpeech generates revenue through a subscription-based model, offering various pricing tiers tailored to the needs of educational institutions, healthcare providers, and individual users. Clients can choose from multiple subscription options based on the number of users and the level of access required, ensuring flexibility in the transaction structure. This approach allows institutions and practitioners to integrate the platform into their existing therapy programs seamlessly. The company’s flagship services are designed to enhance user engagement and outcomes, driving demand across its client base. Additionally, partnerships with schools and therapy centers bolster revenue streams, as these entities may also implement the platform as part of their standard offerings to students and patients.In April 2021, AmplioSpeech Inc. raised USD 27.00 mn in venture funding led by Quad Partners, with participation from Volos Capital. The company plans to utilize this funding to enhance product development and expand its marketing, sales, and customer success operations. AmplioSpeech is focused on increasing its footprint in North America and Europe, targeting educational institutions and healthcare facilities as key markets for growth.

## Funding rounds

- Series A, Apr 5, 2021, $27M — Quad Partners, Volos Capital
- Seed, Jul 1, 2015, $0.6M — Publicis Groupe, Zaitoun Ventures

## Investors

- Publicis Groupe — Seed
- Zaitoun Ventures (https://capitalatlas.ai/funds/zaitoun-ventures) — Seed
- Quad Partners (https://capitalatlas.ai/funds/quad-partners) — Series A
- Volos Capital — Series A